PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026JAMA Pediatrics1 citations

GLP-1 Receptor Agonist Prescriptions for Adolescents With Obesity and Associated Disparities

View Full Paper
CKChungsoo KimMSMona SharifiJRJoseph S. Ross

Key Points

  • The study aims to analyze the patterns of GLP-1 receptor agonist prescriptions among adolescents with obesity and identify any associated disparities.
  • Examined prescribing patterns of GLP-1 receptor agonists in a population of adolescents.
  • Identified demographic factors contributing to disparities in prescriptions.
  • Disparities in the prescription of GLP-1 receptor agonists were observed among different demographic groups.
  • Findings indicate that not all adolescents with obesity receive equal access to GLP-1 therapies.

Abstract

This study examines the prescribing of glucagon-like peptide-1 receptor agonists for adolescents with obesity and associated disparities.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kim et al. (2026) studied this question.

synapsesocial.com/papers/6971bd4c642b1836717e2082https://doi.org/10.1001/jamapediatrics.2025.5708
Ask AI
Helpful
Bookmark
Share
View Full Paper